Ftse Mib
34.938,90
0,45%
DAX
20.340,57
0,65%
S&P 500
5.909,03
-1,11%
NASDAQ
19.489,68
-1,89%
Bitcoin
96.277,07
-0,65%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Prothena Corporation PLC (PRTA) Prothena Corporation PLC (PRTA) Notizie

Prothena Corporation PLC

PRTA
14,16
1,01 (7,68%)
07 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/1/202501:45EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
30/12/202422:07EDGAR2Form 8-K - Current report
30/12/202422:05BWProthena Announces Board of Directors Update
19/12/202407:05BWRoche’s Phase IIb Study of Prasinezumab Missed Primary..
13/11/202413:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:09EDGAR2Form 8-K - Current report
12/11/202422:05BWProthena Reports Third Quarter 2024 Financial Results and..
05/11/202422:05BWProthena to Report Third Quarter 2024 Financial Results on..
04/10/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/9/202422:13EDGAR2Form 8-K - Current report
27/9/202422:05BWProthena Announces Leadership Team Updates
29/8/202422:05BWProthena to Participate in Upcoming Healthcare Conferences
08/8/202423:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:09EDGAR2Form 8-K - Current report
08/8/202422:05BWProthena Reports Second Quarter 2024 Financial Results and..
01/8/202422:05BWProthena to Report Second Quarter 2024 Financial Results on..
28/5/202422:05BWProthena Announces Bristol Myers Squibb Opt-in for Exclusive..
17/5/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:08EDGAR2Form 8-K - Current report
08/5/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:09EDGAR2Form 8-K - Current report
08/5/202422:05BWProthena Reports First Quarter 2024 Financial Results and..
01/5/202422:05BWProthena to Report First Quarter 2024 Financial Results on..
15/4/202422:05BWProthena Announces Review on Birtamimab Mechanism of Action..
06/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202422:05BWProthena to Participate in Upcoming Healthcare Conferences
04/3/202422:05BWProthena Appoints David Ford to Newly Created Chief People..
01/3/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:29EDGAR2Form S-3ASR - Automatic shelf registration statement of..
22/2/202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202422:06EDGAR2Form 8-K - Current report
21/2/202422:05BWProthena Announces Appointment of Daniel G. Welch as..
15/2/202422:09EDGAR2Form 8-K - Current report
15/2/202422:05BWProthena Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202418:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202401:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05BWProthena to Report Fourth Quarter and Full Year 2023..
25/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:06EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 13,14 Min: 12,97 Max: 14,47
Chiusura: 13,15

La tua Cronologia

NASDAQ
PRTA
Prothena
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network